Clinical Trial Update: A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the activity of Caelyx in combination with trastuzumab and docetaxel for metastatic breast cancer; the study has completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)
• HERCEPTIN (trastuzumab)
• Taxotere (docetaxel)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2010-02-15